A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

Clinical trial NCT04543305 · COMPLETED

Trial details

NCT number: NCT04543305
Sponsor: Prelude Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Acute Myeloid Leukemia Non Hodgkin Lymphoma Myelodysplastic Syndromes

Start date: 2020-09-28
Primary completion: 2022-03-21
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.